XCell-Center

XCell-Center was a private German stem cell clinic that offered autologous bone marrow-derived stem cell treatments for a wide range of chronic and degenerative diseases. Founded in 2007, the company operated clinics in Düsseldorf and Cologne, attracting thousands of international patients seeking therapies for conditions such as diabetes, Parkinson's, and spinal cord injuries. The center faced significant controversy and criticism from the global scientific community for providing unproven treatments without rigorous clinical trial evidence or regulatory approval. Following the death of a pediatric patient and changes in German pharmaceutical regulations regarding advanced therapy medicinal products, the company was forced to cease operations in 2011. Its legacy remains a prominent and cautionary example in the debate over unregulated stem cell tourism and patient safety.